BURLINGTON, N.C.—(BUSINESS WIRE)—Feb. 21, 2022— Labcorp (NYSE: LH), a leading global life sciences company, today announced that it has closed its acquisition of Personal Genome Diagnostics Inc. (PGDx), a leader in cancer genomics with a portfolio of comprehensive liquid biopsy and tissue-based products.
Click here to read the full press release on the Labcorp newsroom.